by JM Elste 2024 Cited by 2Package insert. Ipsen Biopharmaceuticals, Inc.; 2024. Google Scholar Vyxeos. Package insert. Jazz Pharmaceuticals, Inc.; 2024
VYXEOS is a cytotoxic drug. Follow applicable special handling and inserted central catheter. An in-line membrane filter may be
PACKAGE LEAFLET. Page 29. 29. Package leaflet: Information for the patient. Vyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusion.
Vyxeos (44 mg daunorubicin and 100 mg cytarabine) liposome, single-dose vial: xx VII. References 1. Vyxeos [package insert]. Palo Alto, CA; Jazz Pharmaceuticals, Inc, August 2024. Accessed May 2024. 2. Referenced with permission from the NCCN Drugs Biologics Compendium (NCCN Compendium ) for cytarabine/daunorubicin liposome.
Vyxeos (44 mg daunorubicin and 100 mg cytarabine) liposome, single-dose vial: −0745−xx. VII. References. Vyxeos [package insert]. Palo
Vyxeos (44 mg daunorubicin and 100 mg cytarabine) liposome, single-dose vial: 0745 xx VII. References 1. Vyxeos [package insert]. Palo Alto, CA; Jazz Pharmaceuticals, Inc, March 2024. Accessed March 2024. 2. Referenced with permission from the NCCN Drugs Biologics Compendium (NCCN Compendium ) for cytarabine/daunorubicin liposome.
Vyxeos (44 mg daunorubicin and 100 mg cytarabine) liposome, single-dose vial: 0745 xx VII. References 1. Vyxeos [package insert]. Palo Alto, CA; Jazz Pharmaceuticals, Inc, March 2024. Accessed June 2024. 2. Referenced with permission from the NCCN Drugs Biologics Compendium (NCCN Compendium ) for cytarabine/daunorubicin liposome.
Monitoring drug levels may be indicated. RESOURCES. Tobramycin Package Insert Gentamicin Package Insert Amikacin Package Insert Streptomycin Package
Vyxeos, approved by the U.S. FDA in 2024, is the first liposomal product However, the EMA insert states: 'In the limited number of patients with prior
I would like to know more about this package. ^.^